Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Nihon Chouzai Co ( (JP:3341) ) has shared an announcement.
Nihon Chouzai Co., Ltd. has announced an impairment loss of 2,084 million yen in its Dispensing Pharmacy Business due to a decline in profitability caused by a changing business environment. Consequently, the company has revised its full-year consolidated earnings forecast, reducing the net income attributable to shareholders by 45.9% to 2,000 million yen for the fiscal year ending March 31, 2025.
More about Nihon Chouzai Co
Nihon Chouzai Co., Ltd. operates in the dispensing pharmacy business, focusing on providing pharmaceutical services and products. The company is listed on the Tokyo Stock Exchange Prime Market.
YTD Price Performance: 0.0%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $253.4M
Find detailed analytics on 3341 stock on TipRanks’ Stock Analysis page.